文献速递心外重症与机械循环支持

左心室辅助装置驱动线出口护理方案的系统综述

Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

各研究出口护理方法差异显著,无标准化 dressing 技术;使用含氯己定、银基敷料和固定装置的 dressing kit 的研究感染率为6-7.5%。作者认为此类方案可能降低感染率,但需更大样本前瞻性研究确定最优方案。

要点

  • LVAD驱动线感染率中位数13.8%,各研究间差异大(0-52.6%)。
  • 含氯己定、银基敷料和固定装置的dressing kit方案感染率为6-7.5%。
  • 固定装置类型和换药频率(每日至每周)无统一标准,未发现某方案更优。

核心结论

  • 包含氯己定、银基敷料、固定装置及dressing kit的驱动线出口护理方案可能最有助于降低驱动线感染率。
  • 需更大样本前瞻性研究确立驱动线出口护理的最优方案。

主要发现

  • 文献中驱动线感染率中位数为13.8%,范围0-52.6%。
  • 驱动线出口护理方法差异显著,LVAD患者无标准化dressing技术。
  • 使用含氯己定、银基敷料和固定装置的dressing kit的研究中,驱动线感染率为6-7.5%。
  • 固定装置类型和换药频率(每日至每周)存在差异,未发现特定固定装置或换药频率更优。

关键数值与推荐

  • 驱动线感染率中位数13.8%(范围0-52.6%)。
  • 使用含氯己定、银基敷料和固定装置的dressing kit的研究感染率为6-7.5%。

临床怎么用

  • 可考虑采用包含氯己定、银基敷料、固定装置及dressing kit的驱动线出口护理方案以降低感染率。
  • 目前尚无统一标准,具体固定装置和换药频率需个体化选择。

局限性

  • 纳入研究间护理方法异质性大,无法汇总确定最优方案。
  • 缺乏大规模前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Driveline infections continue to be a significant complication following left ventricular assist device (LVAD) implantation. Driveline exit-site care is crucial for the prevention of infections; however, there are no uniform guidelines. The goal of this study was to provide an overview of the currently published driveline exit-site care protocols in patients with LVAD. METHODS: A systematic literature review was performed. Studies before 15 December 2020 were included if the number of driveline infections was a primary outcome and the driveline exit-site care protocol was explained. RESULTS: Eleven articles were included in the systematic review, including 1602 patients with LVADs. The median of the frequency of driveline infections in the articles was 13.8% with a range of 0-52.6%. There was a marked variability in the methods of care of driveline exit sites, without a standardized driveline dressing technique in patients with LVADs. The frequency of driveline infections was 6-7.5% in studies using a dressing kit that included chlorhexidine, a silver-based dressing and an anchoring device. Furthermore, there was variability in the anchoring devices and the frequency of dressing changes, which varied from daily to weekly. No specific anchoring device or change frequency was found to be superior. CONCLUSIONS: Based on this systematic review, driveline exit care protocols that included chlorhexidine, a silver-based dressing, the use of an anchoring device and dressing kits might be best in reducing driveline infection rates. However, prospective studies with larger cohorts are needed to establish the optimal protocol for driveline exit-site care.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Koken ZO, Yalcin YC, van Netten D, et al. Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review. Eur J Cardiothorac Surg. 2021. PMID: 33963835. doi:10.1093/ejcts/ezab195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。